Skip to main content
IRRAS logo

IRRAS — Investor Relations & Filings

Ticker · IRRAS ISIN · SE0008321202 LEI · 549300EKKVQN2J25MJ59 ST Manufacturing
Open in API
Filings indexed 130 across all filing types
Latest filing 2023-02-16 Interim / Quarterly Rep…
Country SE Sweden
Listing ST IRRAS

About IRRAS

https://irras.com/

IRRAS is a commercial-stage medical technology company focused on designing, developing, and commercializing innovative solutions for neurocritical care. The company's core technology addresses challenges in fluid control and management for critically ill patients, particularly those with intracranial bleeding. Its primary product, the IRRAflow system, is an intelligent fluid management device that combines controlled irrigation with drainage to manage fluids and monitor intracranial pressure. The system is designed to improve patient outcomes, reduce complications, and decrease the overall cost of care by providing a new standard for treating brain pathologies.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is titled 'YEAR-END REPORT JANUARY–DECEMBER 2022' for IRRAS AB. It contains comprehensive financial statements, including income statements, balance sheet data, and detailed management commentary on business performance, revenue, and expenses for the full fiscal year and the fourth quarter. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR) as it covers a period shorter than a full fiscal year (or in this case, the year-end report which functions as the final quarterly/interim reporting period). FY 2022
2023-02-16 English
IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow[®] System
Regulatory Filings Classification · 1% confidence The document announces a significant business event: a commercial partnership agreement between IRRAS and Medtronic for the promotion of the IRRA*flow* system in the United States. This type of announcement, detailing strategic business arrangements, partnerships, or major commercial agreements that impact the company's operations and market strategy, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). It is a material corporate event announcement. Since it is not a Director's Dealing (DIRS), Capital Change (CAP/SHA), Dividend (DIV), or a specific regulatory filing like a proxy (DEF 14A/PSI), the most appropriate general category for a significant, non-standard corporate announcement that is material to investors is the Regulatory Filings fallback category (RNS), as it is a disclosure made under market regulations (EU Market Abuse Regulation mentioned at the end). However, given the nature of the announcement (a strategic commercial partnership), it is often classified under a general 'Corporate Action' or 'Material Event' category. In the provided list, RNS serves as the best general regulatory/material announcement fallback.
2022-11-14 English
IRRAS tillkännager kommersiellt avtal med Medtronic i USA för IRRAflow-systemet
Regulatory Filings Classification · 1% confidence The document is a press release from IRRAS announcing a commercial agreement with Medtronic regarding the IRRAflow system in the USA. It details the terms of the agreement, provides background on the technology, and includes standard company information. The final paragraph explicitly states: "Denna information är sådan information som IRRAS är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is such information that IRRAS is obliged to disclose pursuant to the EU's Market Abuse Regulation). This strongly indicates a mandatory regulatory disclosure, often categorized as a general regulatory announcement or a specific announcement related to material events. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a director's dealing (DIRS), the most appropriate general regulatory category for a material business event announcement that doesn't fit other specific codes is Regulatory Filings (RNS). It is not an Earnings Release (ER) or a specific Capital/Financing Update (CAP).
2022-11-14 Swedish
IRRAS AB publishes Interim Report for the period January to September 2022
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT JANUARY–SEPTEMBER 2022' and contains comprehensive financial statements, including income statements, key figures, and management commentary on business performance for the specified period. It is clearly a quarterly/interim financial report, not an announcement or a summary. 9M 2022
2022-11-10 English
IRRAS AB publicerar delårsrapport för januari till september 2022
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim Report' (Interim Report Januari–September 2022) for IRRAS AB. It contains comprehensive financial statements, key performance indicators (KPIs), management commentary (VD har ordet), and detailed analysis of business performance for the period. It is not an announcement of a report, but the report itself, containing substantive financial data. 9M 2022
2022-11-10 Swedish
Change in the total number of shares and votes in IRRAS AB
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly announces a 'Change in the total number of shares and votes' due to the registration of newly issued ordinary shares following a rights issue. This directly relates to a change in the company's capital structure (share count). This aligns perfectly with the definition of 'Share Issue/Capital Change' (Code: SHA). The document is short and provides the final figures, making it a direct announcement rather than a proxy solicitation or a general regulatory filing.
2022-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.